Skip to content
  • HOME
  • ABOUT
    • What We Do
    • Team
    • Former Members
    • Community News
  • CONSULTING
    • Projects
    • Example Case Study
    • Consulting FAQs
  • VC
    • Investment Memos
  • COMMUNICATIONS
    • Viewpoints
    • Market Reports
  • EVENTS
  • DIVERSITY
    • Our Statement
    • Action Items
    • Get Involved

T Cell Engineering: Crafting Cellular Warriors Against Cancer

by Dr. Mehdi Soleymani Goloujeh | October 11th, 2024

Introduction to the Challenge of Cancer Cancer is one of the major global health issues, with its incidence steadily increasing and mortality rates on the rise, affecting millions of people each year. In 2022, approximately 20 million new cancer cases and nearly 9.7 million cancer-related deaths were reported worldwide. By 2050, cancer cases are projected […]

Read More

From Pandemics to Progress: A Survey of Venture Capital Investments in Infectious Disease

by Nicole Tanenbaum | October 11th, 2024

From the blow of the Black Death in medieval Europe, to the polio epidemics of the 20th century, and the widespread devastation caused by smallpox, pathogens have continually caused widespread morbidity and mortality. Today, several of these microbes feel like threats of the past. With advancements in controlling infectious diseases, vaccine-preventable deaths have dropped and […]

Read More

A New Era: Key Implications of the Inflation Reduction Act on the Healthcare and Biopharma Ecosystem

by Han Le | February 6, 2024

Jacqueline Racener was diagnosed with leukemia and prescribed a drug offering the hope of combating the cancer with only moderate side effects. However, upon learning that the annual cost would be $8,000, even with her Medicare insurance, Jacqueline opted to stop filling her prescription, hoping that the cancer would not progress further. With cancer drugs […]

Read More

Beyond Antibody Therapies: Novel Therapeutic Approaches to Combat Alzheimer’s Disease

by Nicole Koutsodendris | February 6, 2024

Alzheimer’s disease (AD) is a neurological disorder that affects nearly 6.7 million Americans over the age of 65. The widespread nature of this disease means that many people are impacted by it in some way, whether it is being diagnosed with the disorder, or caring for an afflicted friend or family member. Despite its high […]

Read More

There’s an app for that: Digital Therapeutics

by Meagan Hamblin | June 21, 2023

Sometimes a medical condition can be cured with a single surgery or a course of medications. But many illnesses — like diabetes, asthma, and chronic pain — require long-term treatment and management. Recognizing the assistive potential of smart phones and other personal computing devices, some doctors have begun recommending apps to help patients track their […]

Read More

Is Alcohol Use Disorder virtually solved?

by Zach Hoisington | May 11, 2023

Alcohol use is common in the United States. The vast majority of adults (84.0%) have drunk alcohol at some point in their lifetime, with most of them (79.5%) reporting having a drink in the last year. Many social events rely on the presence of alcohol, and most attend these events without alcohol disrupting their lives. […]

Read More

Ultra-rare genetic diseases: emerging strategies and new challenges

by Joe Aman | December 16, 2022

Genetic diseases, like cystic fibrosis and sickle cell disease, can be devastating to the people afflicted by them, but they often affect few people. The exact cutoffs vary from nation to nation, but in the United States, a rare disease is defined as one that afflicts fewer than 200,000 Americans. Most of these diseases are […]

Read More

Augmented Reality in spine surgery: a promising market niche with an uncertain business future

by Ziwei Pan | December 16, 2022

Imagine you are driving to a friend’s house. You have been there a few times and have formed some general impressions of the route. In the old days, you would only have your imperfect memory to guide you. Now you can use GPS not only to navigate the route, but also to see live traffic […]

Read More

Harvesting our gut communities to treat disease

by Lindsey Fontenot | December 12, 2022

A look at fecal microbiota transplants in universities and biotech companies Trillions of bacteria, along with some fungi, viruses, and archaea, make up our gut microbiome. These bacteria greatly outnumber our own cells and play a crucial role in our bodies. Researchers are exploring gut microbiome interventions to improve human health. In the last several […]

Read More

Promoting innovation in academia: from universities to startups and beyond

by Sarah Van Houten | August 25, 2022

With both industry and the academic community working together, innovative ideas generated at universities could potentially lead to more successful startups and a better workforce.

Read More

Next »

To learn more about how BCBA can
help your business or organization,
please contact us at info@biotechconnectionbay.org

2025 © Biotech Connection - Bay Area, Inc., All Rights Reserved

Biotech Website Design by Thomas Digital

  • HOME
  • ABOUT
    • What We Do
    • Team
    • Former Members
    • Community News
  • CONSULTING
    • Projects
    • Example Case Study
    • Consulting FAQs
  • VC
    • Investment Memos
  • COMMUNICATIONS
    • Viewpoints
    • Market Reports
  • EVENTS
  • DIVERSITY
    • Our Statement
    • Action Items
    • Get Involved